Effects of Solriamfetol on Neuropsychological Outcomes in Patients With Obstructive Sleep Apnea in the Real-world SURWEY Study (P6-14.005)

Key Points

• This research aims to assess how solriamfetol affects neuropsychological outcomes in patients suffering from excessive daytime sleepiness linked to obstructive sleep apnea.
• Conducted as a real-world study (SURWEY) gathering data from patients with obstructive sleep apnea and excessive daytime sleepiness.
• Evaluated the impact of solriamfetol on neuropsychological functions over a specified follow-up duration.
• Findings indicate significant improvements in neuropsychological outcomes in patients treated with solriamfetol.
• The treatment showed effects on reducing excessive daytime sleepiness, enhancing daytime functioning.